Niagen Bioscience (NAGE) Other Working Capital Changes (2011 - 2026)
Niagen Bioscience's (NAGE) quarterly Other Working Capital Changes came in at -$102000.0 in Q1 2026, up 59.36% year-on-year from -$64005.0 in Q1 2025, and down 117.74% on a QoQ basis from $575000.0 in Q3 2025.
Niagen Bioscience (NAGE) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 7 years of Other Working Capital Changes data on file, last reported at -$102000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 59.36% year-over-year to -$102000.0 in Q1 2026; TTM through Mar 2026 was $244000.0, a 126.1% increase from a year earlier, with the FY2025 full-year figure at $95000.0, up 112.98% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$102000.0, down from $575000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for NAGE reached as high as $2.8 million in Q3 2022 and fell as low as -$2.3 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$8941.2 across 5 years, with a median of -$18000.0 in 2022.
- Across the five-year window, Other Working Capital Changes plunged 600.0% in 2024 and jumped 355.56% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$152000.0 in 2022, then surged by 57.24% to -$65000.0 in 2023, then tumbled by 452.31% to -$359000.0 in 2024, then jumped by 260.17% to $575000.0 in 2025, then sank by 117.74% to -$102000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$102000.0 in Q1 2026, $575000.0 in Q3 2025, and -$229000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | 107,000.00 |
| Dec 31, 2025 | 107,000.00 |
| Dec 31, 2025 | 107,000.00 |
| Sep 30, 2025 | -36,000.00 |
| Sep 30, 2025 | -36,000.00 |
| Sep 30, 2025 | -36,000.00 |
| Jun 30, 2025 | -268,000.00 |
| Jun 30, 2025 | -268,000.00 |
| Jun 30, 2025 | -268,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Dec 31, 2024 | 357,000.00 |
| Dec 31, 2024 | 357,000.00 |
| Dec 31, 2024 | 357,000.00 |
| Sep 30, 2024 | -275,000.00 |
| Sep 30, 2024 | -275,000.00 |